Our data demonstrate that circulating levels of LIPCAR and MIAT or SENCR may constitute novel biomarkers of LV diastolic function and remodelling, respectively, in patients with well-controlled type 2 diabetes. Here, SENCR is linked to type 2 diabetes mellitus.